These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25760947)

  • 1. A novel therapy for melanoma developed in mice: transformation of melanoma into dendritic cells with Listeria monocytogenes.
    Bronchalo-Vicente L; Rodriguez-Del Rio E; Freire J; Calderon-Gonzalez R; Frande-Cabanes E; Gomez-Roman JJ; Fernández-Llaca H; Yañez-Diaz S; Alvarez-Dominguez C
    PLoS One; 2015; 10(3):e0117923. PubMed ID: 25760947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system tumor immunity generated by a recombinant listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden.
    Prins RM; Bruhn KW; Craft N; Lin JW; Kim CH; Odesa SK; Miller JF; Liau LM
    Neurosurgery; 2006 Jan; 58(1):169-78; discussion 169-78. PubMed ID: 16385341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection.
    Rodriguez-Del Rio E; Marradi M; Calderon-Gonzalez R; Frande-Cabanes E; Penadés S; Petrovsky N; Alvarez-Dominguez C
    Vaccine; 2015 Mar; 33(12):1465-73. PubMed ID: 25659269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Listeria monocytogenes activated dendritic cell based vaccine for prevention of experimental tumor in mice.
    Khamisabadi M; Arab S; Motamedi M; Khansari N; Moazzeni SM; Gheflati Z; Hadjati J
    Iran J Immunol; 2008 Mar; 5(1):36-44. PubMed ID: 18319523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
    J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.
    Sewell DA; Shahabi V; Gunn GR; Pan ZK; Dominiecki ME; Paterson Y
    Cancer Res; 2004 Dec; 64(24):8821-5. PubMed ID: 15604239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exceptional antineoplastic activity of a dendritic-cell-targeted vaccine loaded with a Listeria peptide proposed against metastatic melanoma.
    Calderon-Gonzalez R; Bronchalo-Vicente L; Freire J; Frande-Cabanes E; Alaez-Alvarez L; Gomez-Roman J; Yañez-Diaz S; Alvarez-Dominguez C
    Oncotarget; 2016 Mar; 7(13):16855-65. PubMed ID: 26942874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients.
    Tuettenberg A; Becker C; Huter E; Knop J; Enk AH; Jonuleit H
    Int J Cancer; 2006 May; 118(10):2617-27. PubMed ID: 16353138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal vaccine using CTL epitope-pulsed dendritic cell confers protection for intracellular pathogen.
    Ozawa Y; Suda T; Nagata T; Hashimoto D; Nakamura Y; Enomoto N; Inui N; Koide Y; Nakamura H; Chida K
    Am J Respir Cell Mol Biol; 2009 Oct; 41(4):440-8. PubMed ID: 19202004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells.
    Fukushima S; Hirata S; Motomura Y; Fukuma D; Matsunaga Y; Ikuta Y; Ikeda T; Kageshita T; Ihn H; Nishimura Y; Senju S
    J Immunother; 2009 Apr; 32(3):219-31. PubMed ID: 19242378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: dendritic cell immunotherapy for melanoma.
    Hadzantonis M; O'Neill H
    Cancer Biother Radiopharm; 1999 Feb; 14(1):11-22. PubMed ID: 10850282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of Zymosan A and bacteria anchored to tumor cells for effective cancer immunotherapy: B16-F10 murine melanoma model.
    Waldmannová E; Caisová V; Fáberová J; Sváčková P; Kovářová M; Sváčková D; Kumžáková Z; Jačková A; Vácová N; Nedbalová P; Horká M; Kopecký J; Ženka J
    Int Immunopharmacol; 2016 Oct; 39():295-306. PubMed ID: 27505858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An H2-T MHC class Ib molecule presents Listeria monocytogenes-derived antigen to immune CD8+ cytotoxic T cells.
    Bouwer HG; Lindahl KF; Baldridge JR; Wagner CR; Barry RA; Hinrichs DJ
    J Immunol; 1994 Jun; 152(11):5352-60. PubMed ID: 8189053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirus-transduced dendritic cells.
    Wan Y; Emtage P; Zhu Q; Foley R; Pilon A; Roberts B; Gauldie J
    Cell Immunol; 1999 Dec; 198(2):131-8. PubMed ID: 10648127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Listeria-based cancer vaccines that segregate immunogenicity from toxicity.
    Brockstedt DG; Giedlin MA; Leong ML; Bahjat KS; Gao Y; Luckett W; Liu W; Cook DN; Portnoy DA; Dubensky TW
    Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13832-7. PubMed ID: 15365184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines and melanoma.
    Ott PA; Fritsch EF; Wu CJ; Dranoff G
    Hematol Oncol Clin North Am; 2014 Jun; 28(3):559-69. PubMed ID: 24880947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cells.
    Lotem M; Machlenkin A; Hamburger T; Nissan A; Kadouri L; Frankenburg S; Gimmon Z; Elias O; David IB; Kuznetz A; Shiloni E; Peretz T
    Clin Cancer Res; 2009 Aug; 15(15):4968-77. PubMed ID: 19602547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells.
    Berger TG; Haendle I; Schrama D; Lüftl M; Bauer N; Pedersen LØ; Schuler-Thurner B; Hohenberger W; Straten Pt Pt; Schuler G; Becker JC
    Int J Cancer; 2004 Aug; 111(2):229-37. PubMed ID: 15197776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.
    Davis ID; Chen Q; Morris L; Quirk J; Stanley M; Tavarnesi ML; Parente P; Cavicchiolo T; Hopkins W; Jackson H; Dimopoulos N; Tai TY; MacGregor D; Browning J; Svobodova S; Caron D; Maraskovsky E; Old LJ; Chen W; Cebon J
    J Immunother; 2006; 29(5):499-511. PubMed ID: 16971806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cytotoxic activity of an infectious, but non-replicative herpes simplex virus type 1 and plasmacytoid dendritic cells against tumour cells.
    Thomann S; Boscheinen JB; Vogel K; Knipe DM; DeLuca N; Gross S; Schuler-Thurner B; Schuster P; Schmidt B
    Immunology; 2015 Oct; 146(2):327-38. PubMed ID: 26194553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.